STERIS EV/EBIT STE

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2020.

Today, Oct 23, 2026: 21.0×
7-year median: 29.5×
Against its 7-year history: 5th; percentile: 0 is its lowest day, 100 its highest
7-year range: 18.7× to 49.3×
Peer median: 21.5×

STERIS' EV/EBIT is 21.0× as of Oct 23, 2026.

That is below its 7-year median of 29.5×, lower than on 95% of days in the last 7 years.

Over that time it ranged from 18.7× in Sep 2026 to 49.3× in Dec 2021.

The median for 10 healthcare stocks of a similar size is 21.5×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	21.0×	18.7×	27.8×
2025	26.5×	24.0×	28.2×
2024	24.4×	24.3×	31.4×
2023	31.0×	28.4×	36.7×
2022	31.6×	28.8×	47.7×
2021	49.3×	29.2×	49.3×
2020	30.3×	20.4×	31.3×

Against its peers

Companies in Healthcare nearest STERIS' size, closest first, today.

Company	EV/EBIT
STESTERIS	21.0×
INCYIncyte	10.1×
THCTenet Healthcare	7.5×
UTHRUnited Therapeutics	16.1×
LHLabcorp	21.6×
DGXQuest Diagnostics	19.5×
ZBHZimmer Biomet	21.5×
MEDPMedpace	31.4×
WSTWest Pharmaceutical Services	39.5×
RVTYRevvity	46.0×
DXCMDexCom	25.3×
Peer median	21.5×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on STERIS

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.